MELANIE NEUNER: Open Payments
NPI 1083498646 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 26 payments from 12 companies in 2025. Trend: 2023 $114 · 2024 $972 · 2025 $998
Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $214 |
| ABBVIE INC. | 7 | $177 |
| Neurocrine BioSciences, Inc. | 1 | $140 |
| Edwards Lifesciences Corporation | 1 | $123 |
| Insulet Corporation | 1 | $114 |
| Phathom Pharmaceuticals, Inc. | 2 | $102 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| PFIZER INC. | 1 | $18 |
Products named: Ozempic, INGREZZA, VRAYLAR, OMNIPOD, VOQUEZNA, Wegovy, QULIPTA, REXULTI.
Industry payments across OH — which companies pay providers there.
